Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-252524
Filing Date
2025-10-28
Accepted
2025-10-28 09:20:51
Documents
93
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alks-20250930.htm   iXBRL 10-Q 3587127
2 EX-10.1 alks-ex10_1.htm EX-10.1 774690
3 EX-10.3 alks-ex10_3.htm EX-10.3 40961
4 EX-31.1 alks-ex31_1.htm EX-31.1 19502
5 EX-31.2 alks-ex31_2.htm EX-31.2 19491
6 EX-32.1 alks-ex32_1.htm EX-32.1 24559
7 GRAPHIC img78446689_0.jpg GRAPHIC 13021
8 GRAPHIC img78446689_1.jpg GRAPHIC 134869
9 GRAPHIC img78446689_2.jpg GRAPHIC 140207
10 GRAPHIC img78446689_3.jpg GRAPHIC 66302
11 GRAPHIC img181185395_0.jpg GRAPHIC 2703
12 GRAPHIC img181185395_1.jpg GRAPHIC 16392
  Complete submission text file 0001193125-25-252524.txt   15114049

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alks-20250930.xsd EX-101.SCH 1400613
96 EXTRACTED XBRL INSTANCE DOCUMENT alks-20250930_htm.xml XML 2902161
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 251421712
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)